Citric Buffered Normal Saline Injection, Solution
Product Images NDC 71288-040

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Citric Buffered Normal Saline (NDC 71288-040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label Principal Display Panel (XENLETA® (lefamulin) tablets, 10-Pack Blister Package)

Xenleta (lefamulin) tablets 600 mg, 10-count oral pack packaging label by Meitheal Pharmaceuticals Inc. The label shows dosing instructions for a 5-day regimen with Day 1 to Day 5 doses in red and blue. The label includes administration instructions, storage conditions, and a visual illustration of the blister pack with red and blue tablet compartments. The label indicates the product is prescription only.*

FDA Label Image

Package Label Principal Display Panel (XENLETA (lefamulin) injection Diluent Bag Carton)

Packaging label for Xenleta (lefamulin acetate) injection diluent by Meitheal Pharmaceuticals Inc. The label details a 10 mM citrate buffered 0.9% sodium chloride injection, sterile and non-pyrogenic, intended for intravenous infusion only. The package contains 6 single-dose IV bags of 250 mL each. The label includes warnings for dilution and infusion time, product and manufacturer information, and barcode.*

FDA Label Image

Package Label Principal Display Panel (XENLETA (lefamulin) injection Diluent Bag Label)

A drug information label for the diluent used with Xenleta (lefamulin) injection solution. It details composition, storage instructions, usage precautions, sterility warnings, and manufacturer information for a 250 mL container of 10 mM citrate buffered 0.9% sodium chloride injection intended for intravenous infusion after adding Xenleta.*

FDA Label Image

Chemical Structure (Xenleta Structure)

Chemical structure diagram of lefamulin acetate, the active ingredient in Xenleta injection solution. The structure shows the molecular arrangement including acetyl, sulfur, hydroxyl groups, and cyclic components.*

FDA Label Image

Package Label Principal Display Panel (XENLETA (lefamulin) injection Carton)

Xenleta 150 mg/15 mL (lefamulin) injection carton for intravenous infusion, containing 6 single-dose vials. The label indicates the active ingredient is lefamulin acetate equivalent to 150 mg lefamulin, sterile and non-pyrogenic. Manufactured by Meitheal Pharmaceuticals Inc. The packaging includes warnings about dilution before use and storage conditions requiring refrigeration.*

FDA Label Image

Package Label Principal Display Panel (XENLETA (lefamulin) injection Vial Label)

Xenleta (lefamulin) injection 150 mg/15 mL vial label for intravenous infusion. The sterile, non-pyrogenic single-dose vial contains 168 mg lefamulin acetate equivalent to 150 mg lefamulin. Labeled by Meitheal Pharmaceuticals Inc., the label includes dilution instructions and warnings for concentrated solution requiring dilution before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.